2023-08-07 13:39:24 ET
- Xeris Pharmaceuticals ( NASDAQ: XERS ) is scheduled to announce Q2 earnings results on Tuesday, August 8th, before market open.
- The consensus EPS Estimate is -$0.11 and the consensus Revenue Estimate is $34.84M (+37.7% Y/Y).
- Over the last 2 years, XERS has beaten EPS estimates 38% of the time and has beaten revenue estimates 75% of the time.
- Over the last 3 months, EPS estimates have seen 1 upward revision and 0 downward. Revenue estimates have seen 2 upward revisions and 1 downward.
For further details see:
Xeris Pharmaceuticals Q2 2023 Earnings Preview